BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17855052)

  • 1. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
    Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
    Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
    Pedersen M; Rönnstrand L; Sun J
    Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts.
    Caruana G; Cambareri AC; Ashman LK
    Oncogene; 1999 Sep; 18(40):5573-81. PubMed ID: 10523834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
    Samayawardhena LA; Hu J; Stein PL; Craig AW
    Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
    Krystal GW; DeBerry CS; Linnekin D; Litz J
    Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity.
    Montero JC; López-Pérez R; San Miguel JF; Pandiella A
    Haematologica; 2008 Jun; 93(6):851-9. PubMed ID: 18443272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cgamma.
    Plo I; Lautier D; Casteran N; Dubreuil P; Arock M; Laurent G
    Oncogene; 2001 Oct; 20(46):6752-63. PubMed ID: 11709710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematopoietic progenitor cells utilise conventional PKC to suppress PKB/Akt activity in response to c-Kit stimulation.
    Edling CE; Pedersen M; Carlsson L; Rönnstrand L; Palmer RH; Hallberg B
    Br J Haematol; 2007 Jan; 136(2):260-8. PubMed ID: 17156394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction and functional cooperation between the serine/threonine kinase bone morphogenetic protein type II receptor with the tyrosine kinase stem cell factor receptor.
    Hassel S; Yakymovych M; Hellman U; Rönnstrand L; Knaus P; Souchelnytskyi S
    J Cell Physiol; 2006 Feb; 206(2):457-67. PubMed ID: 16155937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
    Shivakrupa R; Bernstein A; Watring N; Linnekin D
    Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src family kinases are involved in the differential signaling from two splice forms of c-Kit.
    Voytyuk O; Lennartsson J; Mogi A; Caruana G; Courtneidge S; Ashman LK; Rönnstrand L
    J Biol Chem; 2003 Mar; 278(11):9159-66. PubMed ID: 12511554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3'-kinase is essential for male fertility.
    Blume-Jensen P; Jiang G; Hyman R; Lee KF; O'Gorman S; Hunter T
    Nat Genet; 2000 Feb; 24(2):157-62. PubMed ID: 10655061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell factor/c-Kit interactions regulate human islet-epithelial cluster proliferation and differentiation.
    Li J; Goodyer CG; Fellows F; Wang R
    Int J Biochem Cell Biol; 2006; 38(5-6):961-72. PubMed ID: 16213778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain.
    Jahn T; Seipel P; Coutinho S; Urschel S; Schwarz K; Miething C; Serve H; Peschel C; Duyster J
    Oncogene; 2002 Jul; 21(29):4508-20. PubMed ID: 12085229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction via the stem cell factor receptor/c-Kit.
    Rönnstrand L
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2535-48. PubMed ID: 15526160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chrysin inhibited stem cell factor (SCF)/c-Kit complex-induced cell proliferation in human myeloid leukemia cells.
    Lee SJ; Yoon JH; Song KS
    Biochem Pharmacol; 2007 Jul; 74(2):215-25. PubMed ID: 17493588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of stem cell factor on the growth and radiation survival of tumor cells.
    Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
    Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the erythropoietin and stem-cell-factor receptors.
    Wu H; Klingmüller U; Besmer P; Lodish HF
    Nature; 1995 Sep; 377(6546):242-6. PubMed ID: 7545788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoattractant action and molecular signaling pathways of Kit ligand on mouse primordial germ cells.
    Farini D; La Sala G; Tedesco M; De Felici M
    Dev Biol; 2007 Jun; 306(2):572-83. PubMed ID: 17467686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.